Your browser doesn't support javascript.
loading
Polyamidoamine Nanoparticles for the Oral Administration of Antimalarial Drugs.
Martí Coma-Cros, Elisabet; Biosca, Arnau; Marques, Joana; Carol, Laura; Urbán, Patricia; Berenguer, Diana; Riera, Maria Cristina; Delves, Michael; Sinden, Robert E; Valle-Delgado, Juan José; Spanos, Lefteris; Siden-Kiamos, Inga; Pérez, Paula; Paaijmans, Krijn; Rottmann, Matthias; Manfredi, Amedea; Ferruti, Paolo; Ranucci, Elisabetta; Fernàndez-Busquets, Xavier.
Affiliation
  • Martí Coma-Cros E; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain. elisabet.marti@isglobal.org.
  • Biosca A; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain. elisabet.marti@isglobal.org.
  • Marques J; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain. abiosca@ibecbarcelona.eu.
  • Carol L; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain. abiosca@ibecbarcelona.eu.
  • Urbán P; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain. joana.a.marques@gmail.com.
  • Berenguer D; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain. joana.a.marques@gmail.com.
  • Riera MC; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain. lauracarol.20@gmail.com.
  • Delves M; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain. lauracarol.20@gmail.com.
  • Sinden RE; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain. urban.patricia@gmail.com.
  • Valle-Delgado JJ; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain. urban.patricia@gmail.com.
  • Spanos L; Laboratori de Parasitologia, Departament de Microbiologia i Parasitologia Sanitàries, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, ES-08028 Barcelona, Spain. berenguer.diana@gmail.com.
  • Siden-Kiamos I; Laboratori de Parasitologia, Departament de Microbiologia i Parasitologia Sanitàries, Facultat de Farmàcia, Universitat de Barcelona, Av. Joan XXIII s/n, ES-08028 Barcelona, Spain. mcriera@ub.edu.
  • Pérez P; Department of Life Sciences, Imperial College, South Kensington, London SW7 2AZ, UK. michael.delves@lshtm.ac.uk.
  • Paaijmans K; Department of Life Sciences, Imperial College, South Kensington, London SW7 2AZ, UK. r.sinden@imperial.ac.uk.
  • Rottmann M; Department of Bioproducts and Biosystems, School of Chemical Engineering, Aalto University, P.O. Box 16300, FI-00076 Aalto, Finland. juanjose.valledelgado@aalto.fi.
  • Manfredi A; Institute of Molecular Biology and Biotechnology, FORTH, N. Plastira 100, 700 13 Heraklion, Greece. spanos@imbb.forth.gr.
  • Ferruti P; Institute of Molecular Biology and Biotechnology, FORTH, N. Plastira 100, 700 13 Heraklion, Greece. inga@imbb.forth.gr.
  • Ranucci E; Barcelona Institute for Global Health (ISGlobal, Hospital Clínic-Universitat de Barcelona), Rosselló 149-153, ES-08036 Barcelona, Spain. paupga20@gmail.com.
  • Fernàndez-Busquets X; Nanomalaria Group, Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology, Baldiri Reixac 10-12, ES-08028 Barcelona, Spain. paupga20@gmail.com.
Pharmaceutics ; 10(4)2018 Nov 10.
Article in En | MEDLINE | ID: mdl-30423797

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Type of study: Guideline Language: En Journal: Pharmaceutics Year: 2018 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Type of study: Guideline Language: En Journal: Pharmaceutics Year: 2018 Document type: Article